Fluorescent-based Method May Help Measure Levels of Levodopa in Blood
The levels of levodopa, one of the gold-standard treatments in Parkinson’s disease, may be assessed using a fast,…
Articles by Patricia Inácio, PhD
RESTORE-1 Study of Gene Therapy VY-AADC Suspends Patient Screening Due to COVID-19 Pandemic
The Phase 2 RESTORE-1 trial testing the investigational gene therapy VY-AADC has suspended the screening and enrollment of…
Parkinson’s Dementia Trial of Oral Anavex 2-73 to Continue with Adjustments
Anavex Life Sciences announced plans to continue to screen and enroll patients into its active trials for Alzheimer’s disease…
Study to Test MRI Technique for Possible Early Parkinson’s Diagnosis
A clinical study will test the potential of a specific magnetic resonance imaging (MRI) technique to diagnose Parkinson’s…
Dyskinesia Trial Testing Dipraglurant Postponed Due to COVID-19
A Phase 2/3 trial (Study 301) testing Addex Therapeutic’s candidate dipraglurant for people with levodopa-induced dyskinesia associated with…
Enrollment Ongoing in PROPEL Trial for Prevail’s Gene Therapy PR001
Enrollment in the Phase 1/2 PROPEL trial, evaluating the safety, tolerability, and early efficacy of PR001 — a one-time…
Sangamo, Biogen Team Up to Develop Gene Therapies for Neuromuscular Diseases
Sangamo and Biogen are teaming up to develop gene therapies for Parkinson’s and Alzheimer’s disease, as well…
CDNF Safe in Advanced Parkinson’s, Trial Results Show
Treatment with cerebral dopamine neurotrophic factor (CDNF), developed by Herantis Pharma, was safe and well-tolerated among patients with…
Annovis Given US Patent for Potential Parkinson’s Treatment Expected to Enter Phase 2 Trial
Annovis Bio’s lead investigative therapy ANVS401 (also known as Posiphen) targeting protein buildup in the brain has…
Motion Machine’s Ability to Ease Motor Symptoms in Parkinson’s Entering Trial in Australia
A trial in Australia will test a motion machine, called the Reviver, to understand whether it can improve balance,…